A Compartive Study of Capecitabine and Oxaliplatin versus 5-fluorouracil in Neoadjuvant Chemoradiation for Locally Advanced Rectal Carcinoma

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Soliman
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors A. Soliman1, A. Ibrahim1, M. Khalaf2, H. Abdelhady1, N. Attia3
  • 1Assiut University, Assiut, Egypt, /
  • 2Assiut University Hospital, Assiut, Egypt, /
  • 3South Cancer Institute, Assiut, Egypt, /

Abstract

This study was done mainly at Clinical Oncology department of AUH, to evaluate the efficacy of oxaliplatin and capecitabine based chemoradiation compared to standard CI 5-FU based chemoradiation.